Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Svetlana Fayngerts"'
Autor:
Indu Ramachandran, Daniel E. Lowther, Rebecca Dryer-Minnerly, Ruoxi Wang, Svetlana Fayngerts, Daniel Nunez, Gareth Betts, Natalie Bath, Alex J. Tipping, Luca Melchiori, Jean-Marc Navenot, John Glod, Crystal L. Mackall, Sandra P. D’Angelo, Dejka M. Araujo, Warren A. Chow, George D. Demetri, Mihaela Druta, Brian A. Van Tine, Stephan A. Grupp, Albiruni R. Abdul Razak, Breelyn Wilky, Malini Iyengar, Trupti Trivedi, Erin Van Winkle, Karen Chagin, Rafael Amado, Gwendolyn K. Binder, Samik Basu
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-14 (2019)
Abstract Background Gene-modified autologous T cells expressing NY-ESO-1c259, an affinity-enhanced T-cell receptor (TCR) reactive against the NY-ESO-1-specific HLA-A*02-restricted peptide SLLMWITQC (NY-ESO-1 SPEAR T-cells; GSK 794), have demonstrated
Externí odkaz:
https://doaj.org/article/08dda14b5f1b4ef08600740b083a4b11
Autor:
Gwendolyn K. Binder, Dejka M. Araujo, Daniel Nunez, Samik Basu, Luca Melchiori, Rafael G. Amado, Gareth Betts, Natalie Bath, Rebecca Dryer-Minnerly, Ruoxi Wang, Sandra P. D'Angelo, Mihaela Druta, Malini Iyengar, Albiruni Ryan Abdul Razak, Stephan A. Grupp, Breelyn A. Wilky, Jean Marc Navenot, George D. Demetri, Alex Tipping, Brian A. Van Tine, Erin Van Winkle, Warren Chow, Trupti Trivedi, Indu R. Ramachandran, Svetlana Fayngerts, Karen Chagin, Crystal L. Mackall, Daniel E. Lowther, John Glod
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-14 (2019)
Journal for immunotherapy of cancer, vol 7, iss 1
Journal for Immunotherapy of Cancer
Journal for immunotherapy of cancer, vol 7, iss 1
Journal for Immunotherapy of Cancer
Background Gene-modified autologous T cells expressing NY-ESO-1c259, an affinity-enhanced T-cell receptor (TCR) reactive against the NY-ESO-1-specific HLA-A*02-restricted peptide SLLMWITQC (NY-ESO-1 SPEAR T-cells; GSK 794), have demonstrated clinical